Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Pemphigoid

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Pemphigoid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Danilewicz, M; Kulczycka-Siennicka, L; Stasikowska-Kanicka, O; Wagrowska-Danilewicz, M; Waszczykowska, E; Wozniacka, A; Zebrowska, A1
Barber, LA; Clay, KL; Hood, AF; Johnson, CA; Morelli, JG; Morin, SM; Murphy, RC; Pei, Y; Travers, JB; Williams, DA1
Hachisuka, H; Karashima, T; Okubo, K; Sasai, Y2
Goldstein, SM; Wasserman, SI; Wintroub, BU1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Pemphigoid

ArticleYear
Mast cell and eosinophil mediated damage in bullous pemphigoid.
    Immunology series, 1989, Volume: 46

    Topics: Adrenal Cortex Hormones; Chemotactic Factors; Complement Activation; Eicosanoids; Enzymes; Eosinophils; Histamine Release; Humans; Mast Cells; Models, Biological; Pemphigoid, Bullous; Platelet Activating Factor; Skin

1989

Other Studies

4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Pemphigoid

ArticleYear
Mediators of mast cells in bullous pemphigoid and dermatitis herpetiformis.
    Mediators of inflammation, 2014, Volume: 2014

    Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Chemokines; Dermatitis Herpetiformis; Female; Humans; Immunohistochemistry; Inflammation Mediators; Male; Mast Cells; Matrix Metalloproteinase 9; Middle Aged; Pemphigoid, Bullous; Platelet Activating Factor; Skin; Tumor Necrosis Factor-alpha; Young Adult

2014
Identification and pharmacological characterization of platelet-activating factor and related 1-palmitoyl species in human inflammatory blistering diseases.
    Prostaglandins & other lipid mediators, 1998, Volume: 56, Issue:5-6

    Topics: Animals; Binding, Competitive; Blister; Blotting, Northern; Calcimycin; Calcium; Dose-Response Relationship, Drug; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycerylphosphorylcholine; Humans; Inflammation; KB Cells; Pemphigoid, Bullous; Phosphatidylcholines; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Wistar; Retroviridae; Time Factors; Transduction, Genetic

1998
Bullous pemphigoid antigen expression in Pam 212 cells induced by the addition of platelet activating factor.
    Dermatologica, 1991, Volume: 183, Issue:4

    Topics: Animals; Autoantigens; Carrier Proteins; Collagen; Collagen Type XVII; Cytoskeletal Proteins; Dystonin; In Vitro Techniques; Keratinocytes; Mice; Nerve Tissue Proteins; Non-Fibrillar Collagens; Pemphigoid, Bullous; Platelet Activating Factor

1991
The existence of a platelet-activating factor (Paf-acether)-like substance in blister fluid derived from patients with bullous pemphigoid as demonstrated by human platelet aggregation techniques.
    The Kurume medical journal, 1989, Volume: 36, Issue:4

    Topics: Adult; Aged; Biological Assay; Blister; Female; Humans; Male; Middle Aged; Pemphigoid, Bullous; Platelet Activating Factor; Platelet Aggregation; Skin Diseases, Vesiculobullous

1989